Home Digestive Disorders IBD: Crohn’s Disease What’s Health Canada Saying about Biosimilars?

IBD: Crohn's Disease

What’s Health Canada Saying about Biosimilars?

Tags: ,

 
A biosimilar biologic drug, or biosimilar, is a drug demonstrated to be highly similar to a biologic drug that was already authorized for sale (known as the reference biologic drug).  Biosimilars are approved based on a thorough comparison to a reference drug and may enter the market after the expiry of reference drug patents and data protection. Watch this video to get more insight into what Health Canada is saying about biosimilars!
 

This video was made possible by an unrestricted educational grant by Pfizer Canada. 

Related Articles

IBD Treatment Options: Understanding Your Benefits and Risks Animation

Tags:

Read More

IBD: Crohn’s Disease

Tags:

Read More

Alberta Health Initiative: Phase Two – Infographics
Alberta Health Initiative: Phase Two – Infographics

Tags:

Read More

What’s Health Canada Saying about Biosimilars?

https://www.youtube.com/embed/6DkzQFdyNuY
 
A biosimilar biologic drug, or biosimilar, is a drug demonstrated to be highly similar to a biologic drug that was already authorized for sale (known as the reference biologic drug).  Biosimilars are approved based on a thorough comparison to a reference drug and may enter the market after the expiry of reference drug patents and data protection. Watch this video to get more insight into what Health Canada is saying about biosimilars!